Amplify Weight Loss Drug ... (THNR)
AMEX: THNR
· Real-Time Price · USD
22.86
0.02 (0.07%)
At close: Sep 29, 2025, 3:49 PM
22.92
0.28%
After-hours: Sep 29, 2025, 04:04 PM EDT
THNR Holdings List
As of Sep 29, 2025
The Amplify Weight Loss Drug & Treatment ETF is an equity ETF with a total of 11 individual holdings.
The top holdings are Novo Nordisk A/S at 12.88%, Eli Lilly and Company at 12.06%, Regeneron Pharmaceuticals at 6.65%, Amgen at 6.48%, and Hims & Hers Health at 5.68%.
11
64.81%
Equity
2.97M
21.01
0.5900%
Sector Allocation
Rank | Symbol | Name | Price | % Change | Shares | % Weight |
---|---|---|---|---|---|---|
1 | NVO | Novo Nordisk A/... | 55.52 | -0.17% | 6.89K | 12.88% |
2 | LLY | Eli Lilly and C... | 726.48 | +0.27% | 495 | 12.06% |
3 | REGN | Regeneron Pharm... | 560.75 | -0.56% | 351 | 6.65% |
4 | AMGN | Amgen Inc. | 273.97 | +0.36% | 706 | 6.48% |
5 | HIMS | Hims & Hers Hea... | 59.12 | +1.23% | 2.89K | 5.68% |
6 | ABBV | AbbVie Inc. | 223.19 | +1.17% | 680 | 5.04% |
7 | PFE | Pfizer Inc. | 23.84 | +0.32% | 6.02K | 4.81% |
8 | MRK | Merck & Co., In... | 78.58 | +0.02% | 1.76K | 4.64% |
9 | AZN | AstraZeneca PLC | 74.13 | +0.50% | 1.85K | 4.58% |
10 | SRRK | Scholar Rock Ho... | 38.36 | -1.01% | 1.53K | 1.99% |
11 | MTSR | Metsera, Inc. | 52.10 | -0.29% | 959 | 1.68% |